We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Clinical Research Agreement Sample Contracts

BETWEEN
Clinical Research Agreement • January 30th, 2006 • Northern Way Resources, Inc. • Metal mining • California

Standard Contracts

1 CONTRACT CLINICAL RESEARCH AGREEMENT AMENDMENT # 2 -------------------------- ------------------------------------------------------
Clinical Research Agreement • March 30th, 2001 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
THIS AGREEMENT is made by and between TATO SMLOUVA se uzavírá mezi
Clinical Research Agreement • January 31st, 2020

WHEREAS, SPONSOR is the sponsor of the multi-center/multi- centre Study to clinically evaluate the Study Drug and CRO (or its Affiliate) has been retained by SPONSOR (under a separate

Clinical Research Agreement Guidelines
Clinical Research Agreement • April 21st, 2017
EX-10.39 2 dex1039.htm CLINICAL RESEARCH AGREEMENT CLINICAL RESEARCH AGREEMENT
Clinical Research Agreement • May 5th, 2020 • Texas

THIS Clinical Research Agreement is entered into on the 3rd day of January, 2007 by and between St. George’s Hospital Medical School (trading as St George’s, University of London), an exempt charity organized and existing under the laws of the United Kingdom, with its principal offices located at Cranmer Terrace, London SW17 ORE (hereinafter referred to as “SGUL”) and Mannatech, Inc., a corporation organized and existing under the laws of the State of Texas, USA, with its principal office located at 600 S. Royal Lane, Suite 200, Coppell, Texas 75019 (hereinafter referred to as “MANNATECH”), jointly referred to as the Parties.

CLINICAL RESEARCH AGREEMENT
Clinical Research Agreement • July 15th, 2009

This Agreement, effective as of _____________, is made between XOMA CORPORATION, 2910 Seventh Street, Berkeley, California 94710 ("XOMA") and THE UNIVERSITY OF TEXAS ________, a component of The University of Texas System ("Institution"), for the purpose of conducting a clinical study as set forth in protocol # , entitled _______________ ("Protocol").

CLINICAL RESEARCH AGREEMENTS:
Clinical Research Agreement • May 31st, 2016
RESPONSIBILITIES
Clinical Research Agreement • April 18th, 2008
Contract
Clinical Research Agreement • May 5th, 2020

CLINICAL RESEARCH AGREEMENT SMLOUVA O KLINICKÉM VÝZKUMU This Clinical Research Agreement (the “Agreement”), made valid from date of signature by all parties (the “Validity Date”), is hereby entered into by and between BioCryst Pharmaceuticals, Inc., (the “Sponsor”) located at 4505 Emperor Blvd., Suite 200 Durham NC 27703, USA and Faculty Hospital St. Anna, Pekařská 664/53, 656 91 Brno, represented by, director CompanyNo. (“Institution”), and the principal investigator,(“Investigator”), residence address:, Date of birth: . Tato Smlouva o klinickém výzkumu (dále jen "Smlouva"), platná od data jejího podpisu všemi smluvními stranami ("Datum platnosti"), se tímto uzavírá mezi společností BioCryst Pharmaceuticals, Inc. ("Sponzor") se sídlem na 4505 Emperor Blvd, Suite 200 Durham NC 27703, USA, Fakultní nemocnice u sv. Anny v Brně ("Instituce") se sídlem na Pekařská 664/53, 656 91 Brno, zast.:,ředitelem, IČ: a hlavním zkoušejícím,bytem: ,nar.: ("Zkoušející"). Section 1. INVESTIGATOR1.01 Inst

Intraexaminer repeatability and agreement in stereoacuity measurements made in young adults
Clinical Research Agreement • April 9th, 2015

Department of Optics II (Optometry and Vision), Faculty of Optics and Optometry, Complutense University of Madrid, Madrid 28037, Spain

Clinical Research Agreement
Clinical Research Agreement • July 15th, 2009 • Texas

THIS AGREEMENT is entered into by and between MATRIX PHARMACEUTICAL, INC., with its office and place of business at 1430 O'Brien Drive, Menlo Park, Ca. 94025 ("Sponsor") and The University of Texas _______, _________, ____________, TX _______, ("Research Organization").

CLINICAL RESEARCH AGREEMENT
Clinical Research Agreement • July 12th, 2021 • South Australia

A The Parties have identified a particular clinical research activity as outlined in the Schedule (‘the Study’) in which they desire to collaborate.

THIS AGREEMENT is made by and between TATO SMLOUVA se uzavírá mezi
Clinical Research Agreement • August 31st, 2017

having a place of business at Fakultní nemocnice Hradec Králové, Children’s Clinic, Sokolská 581, 500 05 Hradec Králové – Nový Hradec Králové, Czech Republic

Contract
Clinical Research Agreement • April 9th, 2015

Agreement of angle closure assessments between gonioscopy, anterior segment optical coherence tomography and spectral domain optical coherence tomography

Clinical Research Agreement
Clinical Research Agreement • October 8th, 2015 • Connecticut

The University of Connecticut Health Center, an agency of the State of Connecticut, having a business address at 263 Farmington Avenue, Farmington, Connecticut, 06030.

CLINICAL RESEARCH AGREEMENT
Clinical Research Agreement • July 15th, 2009

This Agreement, effective as of ____________, is made between Genentech, Inc. ("Genentech"), 460 Point San Bruno Boulevard, South San Francisco, California 94080, and The University of Texas _________ ("Study Center") Dallas, Texas (collectively the "Parties") for the purpose of conducting clinical research. Citations to the Code of Federal Regulations ("C.F.R.") in this Agreement are citations to regulations governing investigations of new drugs.

Agreement to Terms and Signature
Clinical Research Agreement • July 29th, 2020

The Sponsor is responsible for selecting only qualified investigators, with sufficient time to conduct the research properly and the appropriate potential to recruit the required number of suitable subjects, as appropriate experts to conduct the research study. Sponsors must comply with all requirements regarding research activities, including federal, state, local, and IRB requirements. Only complete and accurate information should be submitted to the IRB for review and approval.

Contract
Clinical Research Agreement • July 21st, 2020

Agreement of corneal curvature and central corneal thickness obtained from a swept-source OCT and Pentacam in ectopia lentis patients

Contract
Clinical Research Agreement • December 5th, 2019

Clinical Research Agreement Smlouva o klinickém hodnocení Sponsor: FUJIFILM Toyama Chemical Co. Ltd., with its registered and principal office at 14-1, Kyobashi 2-chome, Chuo-ku, Tokyo, 104-0031, Japan (“Sponsor”)Protocol Title: “A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of T-817MA In Patients With Mild Cognitive Impairment Due To Alzheimer’s Diseases Or Mild Alzheimer’s Diseases” with protocol number T817MAEU201 (“the Protocol”) Zadavatel: FUJIFILM Toyama Chemical Co. Ltd., se sídlem 14-1, Kyobashi 2-chome, Chuo-ku, Tokyo, 104-0031, Japonsko („Zadavatel“) Název protokolu: „Multicentrické, randomizované, dvojitě zaslepené, placebem kontrolované klinické hodnocení fáze 2 s paralelními skupinami hodnotící účinnost a bezpečnost přípravku T-817MA u pacientů s mírnou kognitivní poruchou v důsledku Alzheimerovy choroby nebo s mírnou formou Alzheimerovy choroby s číslem protokolu T817MAEU201“ („Proto

Contract
Clinical Research Agreement • June 17th, 2014

Agreement in identification of glaucomatous progression between the optic disc photography and Heidelberg Retina Tomography in young glaucomatous patients

CLINICAL RESEARCH AGREEMENT
Clinical Research Agreement • July 15th, 2009 • Texas

This is an Agreement made by and between Boehringer Ingelheim Pharmaceuticals, Inc., having its principal office at 900 Ridgebury Road, Ridgefield, Connecticut 06877 (hereinafter called "BIPI") and The University of Texas [Component] (hereinafter called "INSTITUTION") having its principal office at [Component address], a Component Institution of The University of Texas System (hereinafter called "SYSTEM").

Repeatability and agreement of CCT measurement in myopia using entacam and ultrasound pachymetry
Clinical Research Agreement • June 26th, 2012

2Department of Ophthalmology, Rikang Hospital, Guangxi Traditional Chinese Medical College, Nanning 530011, Guangxi Zhuang Autonomous Region, China Correspondence to: Xuan-Chu Duan. Department of Ophthalmology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China. duanxchu@yahoo.com.cn

Contract
Clinical Research Agreement • August 12th, 2022
Contract
Clinical Research Agreement • March 10th, 2015

Division of Clinical Research of New Drugs and Therapeutics, Center for Innovative Clinical Medicine, Okayama University Hospital Vice Director Yasuhiro Kawakami

BY AND BETWEEN
Clinical Research Agreement • February 7th, 2023

Of the one part, Mr./Ms. ………………………………………………… and ………………………………………………… Respectively acting in the name and on behalf of ………………………..………. (hereinafter, the SPONSOR), with registered office at ………………………..………., being empowered for this act by deed of power of attorney No ………………………..………., duly registered at the ………………………..………. Companies Registry, executed before the Notary of the ………………………..………. Notarial Association, Mr./Ms. ………………………..………., dated ………………………..………. .

CLINICAL RESEARCH AGREEMENT
Clinical Research Agreement • March 20th, 2014 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances

This Clinical Research Agreement (“Agreement”) is entered into this 5th day of November, 2013 (“Effective Date”) by and between ARCA biopharma Inc. (“Sponsor”), a Delaware corporation with offices at 11080 CirclePoint Road, Suite 140, Westminster, CO 80020, and Duke University (“Duke”), a nonprofit research, education and healthcare institution with an office at 2400 Pratt Street, Durham, North Carolina 27705 (individually, a “Party” and collectively, the “Parties”).

CRG and Phase IV Clinical Research Agreement - Standard Form Checklist
Clinical Research Agreement • August 20th, 2020

The CTRA for Collaborative or Cooperative Group (CRG) Clinical Trial Agreements and the CTRA for Phase 4 Clinical Trials (Medicines) can be downloaded from the Medicines Australia website: http://medicinesaustralia.com.au/issues-information/clinicaltrials/clinical-trials-research-agreements/

Agreement among rapid diagnostic tests, urine malaria tests, and microscopy in malaria diagnosis of
Clinical Research Agreement • October 12th, 2012

Jonathan Ayobami Oyeniyi1, Ibrahim Sebutu Bello1 , Olanrewaju Oloyede Oyegbade1, Azeez Oyemomi Ibrahim2 , Oyeladun Funmi Okunromade3 and Oladipupo Omolade Fakoya1

Agreement between IOLMaster® 500 and Pentacam® HR for keratometry assessment in type 2 diabetic and non- diabetic patients
Clinical Research Agreement • May 26th, 2020

Correspondence to: João N Beato. Department of Ophthalmology, São João Hospital, Al Prof Hernâni Monteiro, Porto 4200-319, Portugal. joao.nuno.beato@gmail.com Received: 2019-06-28 Accepted: 2019-09-27

Clinical Research Agreement Zmluva o klinickom výskume
Clinical Research Agreement • October 24th, 2018

This clinical research agreement (“Agreement”) shall come into force on the date signed by the last of the Parties to sign this Agreement and shall come into effect on the day following publication, within the meaning of section 47a(1) of Act No 40/1964 Coll., the Slovak Civil Code, as amended, in the Central Register of Contracts at www.crz.gov.sk, since the Agreement is subject to mandatory publication, as stipulated under section 5a(1) of Act No 211/2000 Coll. on Free Access to Information, as amended (the "Effective Date"). The Sponsor agrees to publication of this Agreement in accordance with the previous sentence.

THIS AGREEMENT is made by and between TATO SMLOUVA se uzavírá mezi (1) PAREXEL International (IRL) Limited,70 Sir John Rogerson's Quay Dublin 2Ireland(Company number 541507) (hereinafter CRO) (1) PAREXEL International (IRL) Limited,70 Sir John...
Clinical Research Agreement • June 18th, 2019

hereinafter SPONSOR dále jen ZADAVATEL WHEREAS, SPONSOR is the sponsor of the multi- center/multi-centre Study to clinically evaluate the Study Drug and CRO (or its Affiliate) has been retained by SPONSOR (under a separate written agreement) to act as SPONSOR’s contractor and designee in managing the Study for SPONSOR; and VZHLEDEM K TOMU, ŽE ZADAVATEL je sponzorem multicentrického klinického hodnocení zaměřeného na klinické posouzení studijního léčiva a CRO (nebo jeho sesterská společnost) uzavřela se ZADAVATELem samostatnou písemnou smlouvu, na jejímž základě byla pověřena zastupováním ZADAVATELe při vedení klinického hodnocení; WHEREAS Institution and Investigator shall Fully Cooperate with CRO and shall permit CRO to perform any and all of the SPONSOR’s Study obligations and to exercise any and all of SPONSOR’s Study rights that lie with SPONSOR on the basis of Applicable Law and GCP regulations as though such rights were CRO’s own rights, as has been delegated by SPONSOR to CRO; a

Agreement Between Clinician and Patient Ratings of Adaptive Functioning and Developmental History
Clinical Research Agreement • June 8th, 2009

Objective: Psychiatric researchers rely heavily on patient report data for clini- cal research. However, patient reports are prone to defensive and self-presentation biases. Recent research using practice networks has relied on clinician reports, and both forensic and personality dis- order researchers have recently turned to quantified data from clinically expert observers as well. However, critics have raised legitimate concerns about the reli- ability and validity of data from clinician informants. The aim of this study was to assess the validity and diagnostic efficien- cy of clinician reports of their patients’ adaptive functioning and developmen- tal histories, using patient reports as the comparative standard traditionally used in psychiatric research.

CLINICAL RESEARCH AGREEMENT
Clinical Research Agreement • March 12th, 2019 • Agile Therapeutics Inc • Pharmaceutical preparations • New Jersey

THIS CLINICAL RESEARCH AGREEMENT (CRA or Agreement) is entered into effective as of October 26, 2018, between TKL Research, Inc., having its principal place of business at One Promenade Boulevard, Suite 1101/1201, Fair Lawn, New Jersey 07410 (TKL) and Agile Therapeutics, Inc. (Sponsor) having its principal place of business at 101 Poor Farm Road, Princeton, New Jersey 08540 (Sponsor) (together the “Parties”).